| Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification P Fusar-Poli, M Cappucciati, S Borgwardt, SW Woods, J Addington, ... JAMA psychiatry 73 (2), 113-120, 2016 | 516 | 2016 |
| The influence of illness‐related variables, personal resources and context‐related factors on real‐life functioning of people with schizophrenia S Galderisi, A Rossi, P Rocca, A Bertolino, A Mucci, P Bucci, P Rucci, ... World Psychiatry 13 (3), 275-287, 2014 | 502 | 2014 |
| At risk or not at risk? A meta‐analysis of the prognostic accuracy of psychometric interviews for psychosis prediction P Fusar‐Poli, M Cappucciati, G Rutigliano, F Schultze‐Lutter, I Bonoldi, ... World Psychiatry 14 (3), 322-332, 2015 | 310 | 2015 |
| Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis P Fusar-Poli, G Rutigliano, D Stahl, C Davies, I Bonoldi, T Reilly, ... JAMA psychiatry 74 (5), 493-500, 2017 | 288 | 2017 |
| The dark side of the moon: meta-analytical impact of recruitment strategies on risk enrichment in the clinical high risk state for psychosis P Fusar-Poli, F Schultze-Lutter, M Cappucciati, G Rutigliano, I Bonoldi, ... Schizophrenia bulletin 42 (3), 732-743, 2016 | 256 | 2016 |
| Diagnostic stability of ICD/DSM first episode psychosis diagnoses: meta-analysis P Fusar-Poli, M Cappucciati, G Rutigliano, M Heslin, D Stahl, Z Brittenden, ... Schizophrenia bulletin 42 (6), 1395-1406, 2016 | 230 | 2016 |
| Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders P Fusar-Poli, G Rutigliano, D Stahl, C Davies, A De Micheli, ... European Psychiatry 42, 49-54, 2017 | 226* | 2017 |
| Metabolic syndrome and major depression D Marazziti, G Rutigliano, S Baroni, P Landi, L Dell'Osso CNS spectrums 19 (4), 293-304, 2014 | 215 | 2014 |
| Prognosis of brief psychotic episodes: a meta-analysis P Fusar-Poli, M Cappucciati, I Bonoldi, LMC Hui, G Rutigliano, DR Stahl, ... JAMA psychiatry 73 (3), 211-220, 2016 | 183 | 2016 |
| Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis G Rutigliano, L Valmaggia, P Landi, M Frascarelli, M Cappucciati, V Sear, ... Journal of affective disorders 203, 101-110, 2016 | 169 | 2016 |
| Improving prognostic accuracy in subjects at clinical high risk for psychosis: systematic review of predictive models and meta-analytical sequential testing simulation A Schmidt, M Cappucciati, J Radua, G Rutigliano, M Rocchetti, ... Schizophrenia bulletin 43 (2), 375-388, 2017 | 168 | 2017 |
| The case for TAAR1 as a modulator of central nervous system function G Rutigliano, A Accorroni, R Zucchi Frontiers in pharmacology 8, 987, 2018 | 162 | 2018 |
| Peripheral oxytocin and vasopressin: biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis G Rutigliano, M Rocchetti, Y Paloyelis, J Gilleen, A Sardella, ... Psychiatry Research 241, 207-220, 2016 | 160 | 2016 |
| Deconstructing pretest risk enrichment to optimize prediction of psychosis in individuals at clinical high risk P Fusar-Poli, G Rutigliano, D Stahl, A Schmidt, V Ramella-Cravaro, ... JAMA psychiatry 73 (12), 1260-1267, 2016 | 150 | 2016 |
| Diagnostic and prognostic significance of brief limited intermittent psychotic symptoms (BLIPS) in individuals at ultra high risk P Fusar-Poli, M Cappucciati, A De Micheli, G Rutigliano, I Bonoldi, ... Schizophrenia bulletin 43 (1), 48-56, 2017 | 149 | 2017 |
| Towards a standard psychometric diagnostic interview for subjects at ultra high risk of psychosis: CAARMS versus SIPS P Fusar-Poli, M Cappucciati, G Rutigliano, TY Lee, Q Beverly, I Bonoldi, ... Psychiatry journal 2016 (1), 7146341, 2016 | 141 | 2016 |
| ACE2 in the era of SARS-CoV-2: controversies and novel perspectives F Saponaro, G Rutigliano, S Sestito, L Bandini, B Storti, R Bizzarri, ... Frontiers in Molecular Biosciences 7, 588618, 2020 | 116 | 2020 |
| Transdiagnostic risk calculator for the automatic detection of individuals at risk and the prediction of psychosis: second replication in an independent national health service … P Fusar-Poli, N Werbeloff, G Rutigliano, D Oliver, C Davies, D Stahl, ... Schizophrenia Bulletin 45 (3), 562-570, 2019 | 109 | 2019 |
| The complex relationship between self-reported ‘personal recovery’and clinical recovery in schizophrenia A Rossi, M Amore, S Galderisi, P Rocca, A Bertolino, E Aguglia, ... Schizophrenia research 192, 108-112, 2018 | 88 | 2018 |
| Therapeutic potential of TAAR1 agonists in schizophrenia: evidence from preclinical models and clinical studies N Dedic, H Dworak, C Zeni, G Rutigliano, OD Howes International Journal of Molecular Sciences 22 (24), 13185, 2021 | 80 | 2021 |